Corticosteroids suppress in vitro tonsillar proliferation in children with obstructive sleep apnoea

European Respiratory Journal

Volumn 33, Issue 5, 2009, Pages 1077-1084

  Kheirandish Gozal, L ^a   Serpero, L D ^a   Dayyat, E ^a   Kim, J ^a   Goldman, J L ^a   Snow, A ^a   Bhattacharjee, R ^a   Gozal, D ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Corticosteroids; Cytokines; Inflammation; Obstructive sleep apnoea; T lymphocytes; Tonsillar hypertrophy

Indexed keywords

BUDESONIDE; CONCANAVALIN A; DEXAMETHASONE; FLUTICASONE; HISTONE H1; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADENOID; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHILD; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYSOMNOGRAPHY; PRESCHOOL CHILD; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; TONSIL CELL;

ADENOIDECTOMY; ADENOIDS; ANALYSIS OF VARIANCE; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CHILD; CYTOKINES; DEXAMETHASONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GLUCOCORTICOIDS; HUMANS; HYPERTROPHY; MALE; PALATINE TONSIL; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE; STATISTICS, NONPARAMETRIC; TONSILLECTOMY;

EID: 66749087498     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00130608     Document Type: Article

References (37)

1. Lumeng JC, Chervin RD. Epidemiology of pediatric obstructive sleep apnea. ProcAm Thorac Soc 2008; 5: 242-252.
2. Arens R, Marcus CL. Pathophysiology of upper airway obstruction: a developmental perspective. Sleep 2004; 27: 997-1019.
3. Katz ES, D'Ambrosio CM. Pathophysiology of pediatric obstructive sleep apnea. ProcAm Thorac Soc 2008; 5: 253-262.
4. Li AM, Wong E, Kew J, Hui S, Fok TF. Use of tonsil size in the evaluation of obstructive sleep apnoea. Arch Dis Child2002; 87: 156-159.
5. Lam YY, Chan EY, Ng DK, et al. The correlation among obesity, apnea-hypopnea index, and tonsil size in children. Chest 2006; 130: 1751-1756.
6. Brooks LJ, Stephens BM, Bacevice AM. Adenoid size is related to severity but not the number of episodes of obstructive apnea in children. J Pediatr 1998; 132: 682-686.
7. Schechter MS, Section on pediatrics pulmonology, subcommittee on obstructive sleep apnea syndrome 2002 Technical report. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 2002;109: e69.
8. Goldbart AD, Krishna J, Li RC, Serpero LD, Gozal D. Inflammatory mediators in exhaled breath condensate of children with obstructive sleep apnea syndrome. Chest 2006; 130: 143-148.
9. Goldbart AD, Veling MC, Goldman JL, Li RC, Brittian KR, Gozal D. Glucocorticoid receptor subunit expression in adenotonsillar tissue of children with obstructive sleep apnea. Pediatr Res 2005; 57: 232-236.
10. Demain JG, Goetz DW. Pediatric adenoidal hypertrophy and nasal airway obstruction: reduction with aqueous nasal beclomethasone. Pediatrics 1995; 95: 355-364.
11. Brouillette RT, Manoukian JJ, Ducharme FM, et al. Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea. J Pediatr 2001; 138: 838-844.
12. Alexopoulos EI, Kaditis AG, Kalampouka E, et al. Nasal corticosteroids for children with snoring. Pediatr Pulmonol 2004; 38: 161-166.
13. Berlucchi M, Salsi D, Valetti L, Parrinello G, Nicolai P. The role of mometasone furoate aqueous nasal spray in the treatment of adenoidal hypertrophy in the pediatric age group: preliminary results of a prospective, randomized study. Pediatrics 2007; 119: e1392-e1397.
14. Kheirandish-Gozal L, Gozal D. Intranasal budesonide treatment for children with mild obstructive sleep apnea syndrome. Pediatrics 2008; 122: e149-e155.
15. Serpero LD, Kheirandish-Gozal L, Dayyat E, Goldman JL, Kim J, Gozal D. A mixed cell culture model for assessment of proliferation in tonsillar tissues from children with obstructive sleep apnea or recurrent tonsillitis. Laryngoscope 2009; (in press).
16. Montgomery-Downs HE, O'Brien LM, Gulliver TE, Gozal D. Polysomnographic characteristics in normal preschool and early school-aged children. Pediatrics 2006;117: 741-753.
17. McColley SA, Carroll JL, Curtis S, Loughlin GM, Sampson HA. High prevalence of allergic sensitization in children with habitual snoring and obstructive sleep apnea. Chest 1997; 111: 170-173.
18. Stewart MG. Identification and management of undiag- nosed and undertreated allergic rhinitis in adults and children. Clin Exp Allergy 2008; 38: 751-760.
19. Ng DK, Chan CH, Hwang GY, Chow PY, Kwok KL. A review of the roles of allergic rhinitis in childhood obstructive sleep apnea syndrome. Allergy Asthma Proc 2006; 27: 240-242.
20. Carr E, Obholzer R, Caulfield H. A prospective study to determine the incidence of atopy in children undergoing adenotonsillectomy for obstructive sleep apnea. Int J Pediatr Otorhinolaryngol 2007; 71: 19-22.
21. Tauman R, Gulliver TE, Krishna J, et al. Persistence of obstructive sleep apnea syndrome in children after adenotonsillectomy. J Pediatr 2006; 149: 803-808.
22. Alatas N, Baba F. Proliferating active cells, lymphocyte subsets, and dendritic cells in recurrent tonsillitis: their effect on hypertrophy. Arch Otolaryngol Head Neck Surg 2008; 134: 477-483.
23. Musiatowicz M, Wysocka J, Kasprzycka E, Hassmann E. Lymphocyte subpopulations in hypertrophied adenoid in children. Int J Pediatr Otorhinolaryngol 2001; 59: 7-13.
24. Mansson A, Adner M, Cardell LO. Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis. Respir Res 2006; 7: 36.
25. Brandtzaeg P. Immunology of tonsils and adenoids: everything the ENT surgeon needs to know. Int J Pediatr Otorhinolaryngol 2003; 67: Suppl. 1, S69-S76.
26. Goldbart AD, Goldman JL, Veling MC, Gozal D. Leukotriene modifier therapy for adenotonsillar hypertrophy and sleep disordered breathing in children. Am J Resp Crit Care Med 2005; 172: 364-370.
27. Kheirandish L, Goldbart AD, Gozal D. Intranasal steroids and oral leukotriene modifier therapy in residual sleep- disordered breathing following tonsillectomy and adenoidectomy in children. Pediatrics 2006; 117: E61-E66.
28. Boorsma M, Andersson N, Larsson P, Ullman A. Assessment of the relative systemic potency of inhaled fluticasone and budesonide. Eur Respir J 1996; 9: 1427-1432.
29. Kelly HW. Pharmaceutical characteristics that influence the clinical efficacy of inhaled corticosteroids. Ann Allergy Asthma Immunol 2003; 91: 326-334.
30. Johnson M. Development of fluticasone propionate and comparison with other inhaled corticosteroids. J Allergy Clin Immunol 1998; 101: S434-S439.
31. Kaditis AG, Ioannou MG, Chaidas K, et al. Cysteinyl leukotriene receptors are expressed by tonsillar T cells of children with obstructive sleep apnea. Chest 2008; 134:324-331.
32. Johansson-Lindbom B, Ingvarsson S, Borrebaeck CA. Germinal centers regulate human Th2 development. J Immunol 2003; 171: 1657-1666.
33. Park HS, Costalonga M, Reinhardt RL, Dombek PE, Jenkins MK, Cleary PP. Primary induction of CD4 T cell responses in nasal associated lymphoid tissue during group A streptococcal infection. Eur J Immunol 2004; 34:2843-2853.
34. Yokoi H, Okayama Y, Niyonsaba F, et al. Comparison of human tonsillar mast cell localization and ultrastructural observations between IgE-mediated allergic and nonaller-gic donors. Allergy Asthma Proc 2006; 27: 415-421.
35. Pajusto M, Ihalainen N, Pelkonen J, Tarkkanen J, Mattila PS. Human in vivo-activated CD45R0+ CD4+ T cells are susceptible to spontaneous apoptosis that can be inhibited by the chemokine CXCL12 and IL-2, -6, -7, and-15. Eur J Immunol 2004; 34: 2771-2780.
36. de Baey A, Mende I, Baretton G, et al. A subset of human dendritic cells in the T cell area of mucosa-associated lymphoid tissue with a high potential to produce TNF-a. J Immunol 2003; 170: 5089-5094.
37. Komorowska A, Komorowski J, Banasik M, Lewkowicz P, Tchorzewski H. Cytokines locally produced by lymphocytes removed from the hypertrophic nasopharyngeal and palatine tonsils. Int J Pediatr Otorhinolaryngol 2005;69: 937-941.